Table of Contents Table of Contents
Previous Page  70 / 116 Next Page
Information
Show Menu
Previous Page 70 / 116 Next Page
Page Background

RESEARCH, EDUCATION & MEDICINE

SAFETY 101

68

|

WINTER 2017

Effects of Aspirin on Diving

By Peter Buzzacott, MPH, Ph.D., and Jim Chimiak, M.D.

M

y doctor recommended that I take an

81 mg aspirin (a “baby aspirin”) every

day. Has there been any research into

how this might affect recreational

divers’ risk of decompression sickness (DCS)?

Though there is insufficient space here to address every

aspect of this question, my colleague and I will address

a few of the major issues. First, whatever research paper

we read will likely have participants that differ in some

way from recreational divers (they might be Navy divers,

for example) or environmental conditions that differ

(they might involve hyperbaric chamber dives rather

than submersions). Therefore, whenever we look to

research for definitive guidance we look for a meta-

analysis that summarizes everything that has been shown

in gold-standard human experiments. Unfortunately,

there has not yet been a meta-analysis of predive aspirin

use in divers, so we must look at individual studies. This

is a bit like looking at photographs in that they show only

snapshots of particular moments and may not convey

the totality of what was going on at the time.

My colleagues and I found that giving rats a daily

dose of aspirin for two days before hyperbaric diving

reduced the incidence of DCS after a very specific

compression profile. The limitations of this single

study, however, outweigh the practical lessons we can

take from it. In particular, the profile was well beyond

what recreational divers might dive, the experiment was

in a chamber instead of in the water, the dose was very

high, and the signs of DCS in rats are different from

those commonly seen in recreational divers. Although

the results of this small study were not statistically

significant, the experiment did suggest that high doses

of aspirin might have a protective benefit (in rats).

1

This was a potentially important finding because in

2014 the U.S. Food and Drug Administration (FDA)

denied an application to recommend a daily dose of

aspirin for primary prevention of heart attack or stroke.

2

The FDA has approved recommending aspirin for

secondary prevention (in patients who had already had

a stroke or heart attack, for example), but it requires

more evidence before it will approve aspirin for primary

prevention (prescribed as a preventive measure to people

Divers who take aspirin should dive conservatively to

minimize their risk of DCI and be sure they are free

from congestion (i.e., have no difficulty equalizing).

STEPHEN FRINK